有投资者向复星医药提问, 你好,请问AI作为一个最有前景的技术,有改变各行各业的趋势,请问公司有没有开始布局将其使用到研发等经营活动中来提高效率和降低成本等的打算?公司回答表示,投资者您好!公司高度重视且密切关注人工智能(AI)技术在医药医疗领域的变革潜力,目前已开展多项应用和尝试,包括(1)内部已上线基于全球领先基础大模型自研的PharmAID决策智能体平台,可覆盖全员,致力于提升工作效率、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.